METASTATIC PLATINUM-RESISTANT OVARIAN CARCINOMA

Clinical trials for METASTATIC PLATINUM-RESISTANT OVARIAN CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC PLATINUM-RESISTANT OVARIAN CARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC PLATINUM-RESISTANT OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat gynecologic cancers

Disease control Recruiting now

This early-stage study is testing a new combination of two drugs, pelcitoclax and cobimetinib, for women with ovarian or endometrial cancer that has returned after prior treatment. The main goals are to find the safest and most effective dose and to check for side effects. Resear…

Matched conditions: METASTATIC PLATINUM-RESISTANT OVARIAN CARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 11, 2026 14:53 UTC

METASTATIC PLATINUM-RESISTANT OVARIAN CARCINOMA

Get alerted when new METASTATIC PLATINUM-RESISTANT OVARIAN CARCINOMA trials appear

New hope for Tough-to-Treat gynecologic cancers